Eventide Asset Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-255,407	Closed	-$6.17M	–	255
2025 Q1	$6.17M	Sell	255,407 -187,290	-42%	-$5.92M	0.12%	136
2024 Q4	$17.8M	Sell	442,697 -10,272	-2%	-$586K	0.32%	98
2024 Q3	$28.7M	Buy	452,969 +200,000	+79%	+$11.7M	0.49%	66
2024 Q2	$13.4M	Hold	252,969	–	–	0.23%	113
2024 Q1	$20.7M	Sell	252,969 -497,031	-66%	-$22.1M	0.33%	91
2023 Q4	$14M	Hold	750,000	–	–	0.23%	107
2023 Q3	$8.3M	Hold	750,000	–	–	0.15%	128
2023 Q2	$12.2M	Buy	+750,000	New	+$15.7M	0.21%	116
2019 Q2	–	Sell	-1,757,000	Closed	-$17.5M	–	127
2019 Q1	$17.5M	Hold	1,757,000	–	–	0.6%	63
2018 Q4	$13.4M	Buy	1,757,000 +967,000	+122%	+$11.6M	0.6%	58
2018 Q3	$13.8M	Buy	+790,000	New	+$9.4M	0.51%	65